INTEGRATIVE MEDICINE INTRAVENOUS THERAPY:
Natural Support for Many Health Problems
by Mitchell A. Fleisher, M.D., D.Ht., D.A.B.F.M., Dc.A.B.C.T.
There are several, different forms of intravenous (I.V.) therapies that are used in Integrative
CAM (Complementary Alternative Medicine) to help provide effective support for a wide range of
health conditions. Since we are all inevitably victims of stress and the aging process, we can
therefore all potentially benefit at any point in our lives from an Integrative CAM program that
may effectively slow and/or reverse the ravages of stress and time.
Prevention is naturally much more effective than trying to correct an existing condition that is
damaging the body, so it is not surprising that many people with no obvious health problems are
requesting I.V. EDTA chelation, and other Integrative CAM I.V. therapies as an excellent form of
anti-aging, preventative support. Below is an overview of the best of these I.V. therapies.
I.V. EDTA Chelation Therapy is an intravenous (by vein) treatment intended to help
accomplish several, important, health goals:
• To remove toxic heavy metals, such as aluminum, arsenic, cadmium, lead, mercury, nickel,
radioactive elements, etc., from the body
• To remove excessive, abnormal amounts of calcium and iron from the body
• To replenish vital minerals to the body, such as potassium, magnesium, etc.
• To reduce free radical oxidative stress damage to the cells, tissues and organs of the body
• To help promote repair of body cells damaged by free radical oxidative stress and toxins
• To help prevent and reverse the formation of vascular plaque (hardening of the arteries)
• To help improve immune system function against abnormal cells and infections
• To help improve blood circulation and oxygenation throughout the body
• To help significantly promote anti-aging of the entire body
The word “chelation” comes from the Greek word “chele” meaning claw. EDTA is a molecule
that will wrap itself around a toxic molecule, inactivate it, and remove it through the urine.
Heavy metals, e.g., aluminum, arsenic, cadmium, lead, mercury, radioactive elements, etc., are
not only directly toxic to cells, but are also powerful generators of free radical oxidative stress.
The active ingredient is EDTA (Ethylene-Diamine-Tetraacetic-Acid), a synthetic amino acid,
recognized as “G.R.A.S.” (“Generally Regarded As Safe”) by the U.S. Food and Drug
Administration (FDA). When administered intravenously, the EDTA traps toxins in the body,
and eliminates them through the kidneys. Many of these toxic materials have been
accumulating in our bodies since childhood. It is these toxic materials that contribute to and
accelerate aging and disease. EDTA helps to remove these harmful toxins, actually allowing
the body to subsequently repair damage done by these toxic substances, after which the body
can then function more normally.
Industrial use of chelating chemicals has been widespread since the 1920s. The first research
for human application of EDTA was prior to WW II, when chelating agents were evaluated as a
treatment for victims of chemical warfare. In the U.S., in the late 1940s, the first human patients
to be treated with EDTA were workers who had been exposed to lead, i.e., lead miners, battery
factory workers, and U.S. Navy ship painters. Interestingly, several of the workers given I.V.
EDTA chelation therapy, who had coexisting health problems, such as angina pectoris, arthritis,
diabetes, high blood pressure, etc., were found to have an unexpected improvement of their
other chronic conditions.
These unexpected improvements in other chronic health conditions created an interest in further
evaluating these benefits obtained from I.V. EDTA chelation therapy. As the clinical I.V. therapy
of other chronic conditions progressed, the benefits were noted to be significant. Many patients
were offered a second chance at good health without need for extreme treatment interventions.
A study published in Medical Hypotheses, “EDTA Chelation Therapy in Chronic Degenerative
Disease” by Dr. James P. Carter (Chief of Nutrition Section, Tulane University, School of Public
Health & Tropical Medicine), and Dr. Efraim Olszewer (Clinical Cardiology) (Vol. 27, Issue 1,
September 1988, 41-49), involving 2,870 patients treated with I.V. EDTA chelation therapy
showed “marked” or “good” improvement for 93% of the patients with ischemic heart disease,
and for 98.6% of the patients with peripheral vascular disease. There are over 3,000 articles in
the medical literature documenting the benefits of I.V. EDTA Chelation therapy.
I.V. EDTA Chelation therapy is amongst the safest of modern, medical treatments. Well over
one million patients have received over 10 million treatments. In over the past thirty years, there
have been no documented deaths from EDTA chelation therapy, when the protocol of the
American College for Advancement in Medicine (ACAM) has been followed. There is even an
FDA approved dosing schedule for children. The only potential risk is related to the dosing of
excessive quantities of EDTA, so therefore, each individual patient’s dose is carefully calculated
by the physician according to the ACAM protocol to assure safety.
I.V. EDTA chelation is a supportive therapy to be seriously considered by persons suffering from
disease of the blood vessels of the heart (coronary artery disease), of the brain, including the
carotid arteries (cerebrovascular disease), of the limbs (peripheral vascular disease),
generalized atherosclerosis (hardening of the arteries), and exposure to toxic materials, e.g.,
heavy metals, as well as other related ailments that promote an accelerated physical decline
due to free radical oxidative stress and toxicity.
I.V. EDTA chelation therapy may possibly help in certain cases to avoid the need for arterial
bypass surgery or angioplasty, as well as to improve the results of these vascular procedures if
they have already been performed. However, EDTA chelation therapy and surgery are not
mutually exclusive, and can be used together for increased therapeutic benefits. Very severe,
potentially life and/or limb threatening arterial blockages may still need vascular bypass surgery
or angioplasty. Even if surgery becomes necessary in the future, the potential benefits of I.V.
EDTA chelation therapy for generalized improvement in the entire circulatory system can
enhance the surgical results and accelerate recovery.
I.V. vitamin therapies include:
• I.V. Vitamin C
• I.V. Myer’s Cocktail
• I.V. Immune Therapy
I.V. vitamin treatments, consisting of various, high potency dosages of Vitamin C, B vitamins,
magnesium, calcium and trace minerals, may be used to support the body’s natural defenses
against a wide variety of health conditions, including angina pectoris, asthma, migraines,
menstrual cramps, infections, such as influenza, Lyme disease, hepatitis, bronchitis,
pneumonia, etc., inflammatory diseases, e.g., arthritis, colitis, etc., autoimmune disorders,
gluten-related diseases, chronic fatigue syndrome, fibromyalgia, malabsorption syndrome,
malnutrition, and for generally improving immune function.
Vitamin C is a vitally important nutrient in the function of our body. I.V. Vitamin C in high doses
may be used: 1) to enhance and balance our immune system function; 2) to help control
inflammation due to allergic, autoimmune, and infectious processes; 3) to play a role in the
elimination of abnormal cells and detoxification; 4) to serve as an antioxidant; and, 5) to support
collagen synthesis, and wound healing. Research studies and the documented, clinical
experiences of Dr. Frederick Klenner, Dr. Hugh Riordan, Dr. Jonathan Wright and others have
shown that the powerful, anti-inflammatory, immune supportive effects of high dose Vitamin C
may be effective in helping a wide variety of viral illnesses, as well as in Lyme Disease, etc.
Glutathione is a naturally occurring peptide that protects every cell, tissue and organ from free
radical oxidative stress and toxicity. It is the most powerful antioxidant inside of our cells, and is
often referred to as the ‘master antioxidant.’ I.V. Glutathione has several functions:
• Helps detoxification, esp. in the liver, which is the chemical factory of the body
• Plays an important role in DNA synthesis and repair
• Regulates and regenerates immune cells
• Provides potential, anti-viral properties
Dr. David Perlmutter, a world-renowned board-certified neurologist, has been using glutathione
to help treat Parkinson’s disease. Although it is not a cure, it has been shown to improve the
symptoms of the disease and possibly slow progression of the illness. In addition, Dr.
Perlmutter has treated a variety of degenerative neurologic conditions with glutathione, including
ALS, Multiple Sclerosis, and Alzheimer’s disease. Some physicians and researchers have also
advocated the use of I.V. glutathione therapy for the symptoms of chronic fatigue syndrome,
fibromyalgia, memory loss, dementia, peripheral neuropathy, and post-stroke syndrome.
I.V. Bio-Oxidative Therapy, consisting of medicinal grade hydrogen peroxide and trace
minerals, is used to help support immune function, especially for infections, e.g., influenza, viral
hepatitis, Lyme disease, etc. The greatly enhanced, tissue oxygenation, i.e., up to twelve
atmospheres of oxygen, provided by I.V. Bio-Oxidative Therapy has also been used to support
improved cellular function in chronic fatigue immune deficiency syndrome (CFIDS),
fibromyalgia, vascular disorders of the heart, brain, and other organ systems.
Administration of Integrative CAM I.V. therapies are usually given over a two to three-hour
period. A “mini” Myer’s Cocktail can be given over a thirty-minute period for patients who do not
have time for a 3-hour I.V. drip. Typically, supportive I.V. treatments are given once or twice a
week, depending on the patient’s illness, and level of vitality.
For more information about Integrative CAM I.V. Therapy, please call the medical office of Dr.
Mitch Fleisher at (434) 361-1896 in Nellysford, VA, in the mountain valley below Wintergreen
Resort, located at the Rockfish Center, Suite 1, 1543 Beech Grove Rd., Roseland, VA 22967.